Skip to main content

Table 5 Five-year overall survival for stage III breast cancer

From: Five-year disease-free survival among stage II-IV breast cancer patients receiving FAC and AC chemotherapy in phase II clinical trials of Panagen

  Chemotherapy + Placebo Chemotherapy + Panagen [25] [24]
Patients Survived patients % Patients Survived patients % Survival, % Survival, %
IIIA 2 1 50 50 7 7 100 79 57 66.7
IIIB 6 3 50 12 8 67 41
IIIC 0 -   - 6 6   100   
Stage III, total 8 4   50 25 21   84